BR9809103A - Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos - Google Patents

Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos

Info

Publication number
BR9809103A
BR9809103A BR9809103-4A BR9809103A BR9809103A BR 9809103 A BR9809103 A BR 9809103A BR 9809103 A BR9809103 A BR 9809103A BR 9809103 A BR9809103 A BR 9809103A
Authority
BR
Brazil
Prior art keywords
peptides
proteins
nucleic acids
acids
administration
Prior art date
Application number
BR9809103-4A
Other languages
English (en)
Inventor
Wolfgang Roedel
Markus Mattern
Gerhard Winter
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of BR9809103A publication Critical patent/BR9809103A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>"FORMA FARMACêUTICA ESTáVEL DE ADMINISTRAçãO PARA PEPTìDEOS, PROTEìNAS E áCIDOS NUCLéICOS''<D>. A invenção refere-se a preparações liofilizadas estáveis em estocagem de biomoléculas em que as biomoléculas são selecionadas do grupo que compreende proteínas, peptídeos, ácido nucléicos e carboidratos e adicionalmente contêm um ou vários D ou L-aminoácidos em adição a um ou vários ácidos aminodicarboxílicos, ácidos hidroxicarboxílicos ou ácidos dicarboxílicos ou sais fisiologicamente compatíveis dos mesmos. As substâncias auxiliares estão presentes no liofilizado em uma forma completamente ou parcialmente amorfa.
BR9809103-4A 1997-04-18 1998-04-11 Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos BR9809103A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19716154A DE19716154A1 (de) 1997-04-18 1997-04-18 Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren
PCT/EP1998/002131 WO1998047490A1 (de) 1997-04-18 1998-04-11 Stabile pharmazeutische darreichungsform für peptide, proteine und nukleinsäuren

Publications (1)

Publication Number Publication Date
BR9809103A true BR9809103A (pt) 2000-08-01

Family

ID=7826847

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809103-4A BR9809103A (pt) 1997-04-18 1998-04-11 Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos

Country Status (10)

Country Link
EP (1) EP0975335A1 (pt)
JP (1) JP2001524090A (pt)
KR (1) KR20010006562A (pt)
CN (1) CN1261271A (pt)
AU (1) AU744777B2 (pt)
BR (1) BR9809103A (pt)
CA (1) CA2288649A1 (pt)
DE (1) DE19716154A1 (pt)
TR (1) TR199902575T2 (pt)
WO (1) WO1998047490A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100625385B1 (ko) * 1998-03-13 2006-09-18 와이어쓰 폴리뉴클레오티드 조성물, 이의 제조방법, 및 용도
US7276359B1 (en) 1998-03-13 2007-10-02 Wyeth Polynucleotide composition, method of preparation, and use thereof
EP1555033A3 (en) * 1998-03-13 2005-08-17 Wyeth Polynucleotide composition, method of preparation, and use thereof
DE19840531C2 (de) * 1998-08-28 2003-05-15 Roboscreen Ges Fuer Molekulare Mit Nukleinsäuren beschichtete Reaktionsräume, Verfahren zu ihrer Herstellung und ihre Verwendung
AU5103200A (en) * 1999-05-31 2000-12-18 Mitsubishi Chemical Corporation Freeze dried hgf preparations
DE10149030A1 (de) * 2001-10-05 2003-04-10 Viscum Ag Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin
JP2007501224A (ja) * 2003-08-05 2007-01-25 フジ フォト フィルム ビー．ブイ． 安定剤としての組換え又は合成ゼラチン様タンパク質の、凍結乾燥医薬組成物中の使用
JP2008509226A (ja) * 2004-05-24 2008-03-27 ジェンボールト コーポレイション 回収可能な形式での安定なタンパク質保管および安定な核酸保管
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
US20090163421A1 (en) * 2007-12-19 2009-06-25 Ekr Therapeutics, Inc. Room Temperature Stable, Lyophilized Natriuretic Peptide Formulations
WO2010031007A2 (en) 2008-09-12 2010-03-18 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
JP2016109914A (ja) 2014-12-08 2016-06-20 三星ディスプレイ株式會社Ｓａｍｓｕｎｇ Ｄｉｓｐｌａｙ Ｃｏ．，Ｌｔｄ． 表示装置、表示方法、及びプログラム
JP2016109911A (ja) 2014-12-08 2016-06-20 三星ディスプレイ株式會社Ｓａｍｓｕｎｇ Ｄｉｓｐｌａｙ Ｃｏ．，Ｌｔｄ． 表示装置、表示方法、及びプログラム
KR102369835B1 (ko) 2014-12-08 2022-03-04 삼성디스플레이 주식회사 표시 장치 및 표시 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63115822A (ja) * 1986-11-04 1988-05-20 Teijin Ltd 生理活性ポリペプチド類の経鼻投与用粉末状組成物
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
DE19538687A1 (de) * 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon

Also Published As

Publication number Publication date
AU744777B2 (en) 2002-03-07
JP2001524090A (ja) 2001-11-27
CN1261271A (zh) 2000-07-26
CA2288649A1 (en) 1998-10-29
AU7758598A (en) 1998-11-13
KR20010006562A (ko) 2001-01-26
EP0975335A1 (de) 2000-02-02
DE19716154A1 (de) 1998-10-22
WO1998047490A1 (de) 1998-10-29
TR199902575T2 (xx) 2000-02-21

Similar Documents

Publication Publication Date Title
BR9809103A (pt) Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos
ES2563677T3 (es) Composiciones de combinaciones de Neisseria
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
ATE333464T1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
KR890004718A (ko) 안정한 인체 단백질의 제조
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
HK1030768A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents.
KR920019371A (ko) 안정화된 인자 ⅷ 제제
DE69906128T2 (de) Reaktionsprodukte von hyaluronsäure und natürlichen aminosäuren sowie deren verwendung in kosmetischen und pharmazeutischen zusammensetzungen
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
CY1106769T1 (el) Λυοφιλοποιησιμη φαρμακευτικη συνθεση εικονικου φαρμακου προοριζομενη για τη μιμηση ενος φαρμακου, ειδικα με βαση πρωτεϊνες ή πολυπεπτιδια
DE69715414D1 (de) Stabilisierte pharmazeutische zusammensetzung von bdnf
PT1079849E (pt) Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
FR2741076B1 (fr) Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
EP1174439A3 (en) Compositions and methods for treating infections using analogues of indolicidin
WO2003002598A3 (en) Peptides for use as translocation factors
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
TH27915B (th) การปรับปรุงความสามารถที่จะทนทานได้ของกรด(สูตร)- อะมิโนที่ออกฤทธิ์ทางเภสัชกรรม

Legal Events

Date Code Title Description
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1891 DE 03/04/2007.